Human Metabolome Technologies, Inc. (6090) Stock Statistics & Valuation Metrics

Human Metabolome Technologies, Inc. has a market cap or net worth of ¥4.68B. The enterprise value is ¥3.06B.

Human Metabolome Technologies, Inc. has 5,919,797 shares outstanding. The number of shares has decreased by -2.65% in one year.

Human Metabolome Technologies, Inc.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 9.36%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Human Metabolome Technologies, Inc. had revenue of 1.35B and earned 243.25M in profits. Earnings per share was 41.14.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Human Metabolome Technologies, Inc. pays an annual dividend of ¥15, resulting in a dividend yield of 1.94%

Human Metabolome Technologies, Inc. upcoming earnings date is Aug 8, 2025, TBA (Confirmed).

Human Metabolome Technologies, Inc. as a current ratio of 3.31, with Debt / Equity ratio of 10.34%

In the past 12 months, Human Metabolome Technologies, Inc. has paid 18.65M in taxes.

Human Metabolome Technologies, Inc. EV to EBITDA ratio is 6.14, with an EV/FCF ratio of 10.61.

Human Metabolome Technologies, Inc. has ¥1.60B in cash and marketable securities with ¥218.00M in debt, giving a net cash position of -¥1.38B billion.

Gross margin is 65.86%, with operating margin of 16.36%, and net profit margin of 18.08%.

The average price target for Human Metabolome Technologies, Inc. is ¥922.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy